ME Stock Recent News
ME LATEST HEADLINES
A class action lawsuit, resignations, layoffs, and other problems have plagued 23andMe. The DNA testing company's latest headache has seen it filing for bankruptcy as its CEO resigns.
DNA testing pioneer 23andMe filed for bankruptcy — sparking fresh concerns about safeguarding the personal data of the company's more than 15 million customers.
US genetic testing company 23andMe has filed for bankruptcy and is looking for a buyer, after rejecting a takeover offer from its resigning CEO.
DNA testing firm 23andMe has filed for Chapter 11 bankruptcy protection.
The genetic testing company, which plans to try to sell all of its assets, holds biological information on millions of people.
23andMe filed for Chapter 11 bankruptcy protection and CEO Anne Wojcicki resigned. 23andMe faced major hurdles in recent months including a $30 million data breach settlement.
23andMe filed for Chapter 11 bankruptcy protection in Missouri federal court on Sunday night. Anne Wojcicki has resigned from her role as chief executive effective immediately, though she will remain a member of the board.
Shares of DNA testing giant 23andMe (ME) are set to open around $1 Monday morning after the company filed for Chapter 11 bankruptcy, and announced the resignation of its CEO on Sunday.
DNA and genetic testing firm 23andMe is in turmoil following a 2023 data breach and its ongoing financial decline. The once-pioneering giant now faces an uncertain future as bankruptcy looms over the company, intensifying concerns about what might happen to the genetic data of 23andMe's some 15 million customers.
23andMe filed for Chapter 11 bankruptcy and CEO Anne Wojcicki has stepped down. The DNA testing company faced challenges including a failed privatization attempt and a data breach.